⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
VRCA News
Verrica Pharmaceuticals Inc. Common Stock
Form 8-K
sec.gov
VRCA
Verrica Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results
globenewswire.com
VRCA
Verrica Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results
globenewswire.com
VRCA
Verrica Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results and Provide a Corporate Update on March 11, 2026
globenewswire.com
VRCA
Verrica Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results and Provide a Corporate Update on March 11, 2026
globenewswire.com
VRCA
Verrica Pharmaceuticals to Participate in the TD Cowen 46th Annual Health Care Conference
globenewswire.com
VRCA
Verrica Pharmaceuticals Appoints Chris Chapman as Chief Commercial Officer
globenewswire.com
VRCA
Verrica Pharmaceuticals Announces Launch of YCANTH® for the Treatment of Molluscum Contagiosum in Japan by Partner Torii Pharmaceutical
globenewswire.com
VRCA
Verrica Pharmaceuticals Announces First Patient Dosed in Phase 3 Program Evaluating YCANTH® (VP-102) for the Treatment of Common Warts
globenewswire.com
VRCA
Basal Cell Carcinoma Market Poised for Steady Growth Throughout Forecast Period (2025-2034) Driven by Novel Drug Approvals and Expanding Patient Pool | DelveInsight
prnewswire.com
VRCA
REGN
NVS
GENK